Bbr Partners, LLC Novartis Ag Transaction History

Bbr Partners, LLC

$1.3 Billion
Q3 2024

A detailed history of Bbr Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bbr Partners, LLC holds 2,565 shares of NVS stock, worth $268,991. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,565

Previous 2,565 -0.0%

Holding current value

$268,991

Previous $273,000 8.06%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$92.57 - $107.37 $425,174 - $493,150	-4,593 Reduced 64.17%	2,565 $273,000
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $281,903 - $320,962	2,959 Added 70.47%	7,158 $692,000
Q4 2023 Feb 12, 2024	BUY	$92.27 - $101.54 $131,946 - $145,202	1,430 Added 51.64%	4,199 $423,000
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $16,326 - $18,933	204 Added 7.95%	2,769 $254,000
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $193,785 - $237,313	2,565 New	2,565 $232,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $56,717 - $64,158	-708 Reduced 21.63%	2,565 $225,000
Q4 2021 Feb 08, 2022	BUY	$79.7 - $88.13 $56,427 - $62,396	708 Added 27.6%	3,273 $286,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $39,295 - $43,403	-461 Reduced 15.23%	2,565 $234,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $167 - $196	-2 Reduced 0.07%	3,026 $259,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $503,353 - $557,648	-6,128 Reduced 66.93%	3,028 $263,000
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $484,366 - $545,233	-5,985 Reduced 39.53%	9,156 $800,000
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $160,067 - $224,257	-2,265 Reduced 13.01%	15,141 $1.25 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $1.04 Million - $1.17 Million	12,309 Added 241.49%	17,406 $1.65 Million
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $14,627 - $16,118	171 Added 3.47%	5,097 $443,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $43,430 - $53,452	576 Added 13.24%	4,926 $450,000
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $753 - $861	-10 Reduced 0.23%	4,350 $418,000
Q4 2018 Feb 08, 2019	BUY	$73.66 - $82.02 $736 - $820	10 Added 0.23%	4,360 $374,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $14,539 - $16,432	-224 Reduced 4.9%	4,350 $329,000
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $321,963 - $384,902	4,574 New	4,574 $370,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.

Account